awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53073031-893C15A8-EEB3-42B0-9DCF-990B34E304B9
Q53073031-893C15A8-EEB3-42B0-9DCF-990B34E304B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53073031-893C15A8-EEB3-42B0-9DCF-990B34E304B9
Bioavailability and bioequivalence comparison of brivaracetam 10, 50, 75, and 100 mg tablets and 100 mg intravenous bolus.
P2860
Q53073031-893C15A8-EEB3-42B0-9DCF-990B34E304B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53073031-893C15A8-EEB3-42B0-9DCF-990B34E304B9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
37e66a336cb6d8cbbf37ee96399ef2fc9834644c
P2860
A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.